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s.2013.09Abstract The endogenous vitamins such as pyridoxal (vitamin B6) and all-trans retinaldehyde
(vitamin A) are metabolized to more or less toxic metabolites by drug-metabolizing enzymes includ-
ing aldehyde oxidase (AO; EC 1.2.3.1). To better understand this function, the speciﬁcity of the rab-
bit liver aldehyde oxidase enzyme toward endogenous vitamins was quantitatively studied.
Therefore, the present study showed the kinetic parameters of AO for the oxidation of vitamin
B6 and vitamin A were measured in partially puriﬁed rabbit liver fraction. Km values of AO endog-
enous vitamin were observed with pyridoxal (21 ± 6.4 lM) and all-trans-retinal (46 ± 9.1 lM)
respectively for partially puriﬁed rabbit liver fraction. AO from rabbit liver fraction showed high
Vmax with vitamin B6 and vitamin A (1.84 ± 0.2 and 1.28 ± 0.1 nmol/min/mg protein, respec-
tively). Therefore, the present study showed the kinetic parameters of AO for the oxidation of
vitamin B6 and vitamin A were measured in partially puriﬁed rabbit liver fraction. A high afﬁnity
and low Km values of AO endogenous vitamin were observed with pyridoxal (21 ± 6.4 lM) and
all-trans-retinal (46 ± 9.1 lM), respectively for partially puriﬁed rabbit liver fraction. Pyridoxal
and all-trans-retinal oxidized to their metabolites (25.2 ± 12.7 and 13.3 ± 4.1 nmol/min/mg
protein, respectively) by partially puriﬁed rabbit liver aldehyde oxidase. These results conﬁrmed
that the hydrophobicity enhances afﬁnity of pyridoxal and all-trans-retinal (aromatic aldehyde)
toward AO as excellent substrates. It is concluded these results presented serve as a guide for
predicting the susceptibility of endogenous to oxidation by rabbit liver AO.
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.0021. Introduction
Xenobiotics are compounds that are foreign to the body, which
include drugs, pollutants and other substances that are not nor-
mally present in the body and are potentially toxic. Xenobiotic
metabolism is the series of metabolic reactions that change the
chemical structure of xenobiotics; generally acting to detoxify
the toxic chemical compounds. Sometimes, however, the prod-
uct of xenobiotic metabolism can be the cause of toxic effects
(Hodgson and Smart, 2001). Of the biotransformations thating Saud University.
68 K.S. Al salhenoccur in animals oxidation plays a major role in the metabolism
of foreign compounds. Although the microsomal cytochrome
P-450 mono-oxygenase system is of major importance in this
respect, enzymes present in the cytosol also contribute to this
process. This study is concerned with the enzyme aldehyde oxi-
dase (AO; EC 1.2.3.1) which is a molybdo-ﬂavoenzyme found
in nearly every organism from bacteria to humans (Beedham,
2001; Garattini et al., 2003, 2008, 2009; Garattini and Terao,
2011). AO catalyzes the oxidation of many different N-hetero-
cyclic compounds as well as aliphatic and aromatic aldehydes
to their corresponding lactam and carboxylic acids respectively
(Beedham, 2001; Garattini etal., 2003, 2008; Garattini and Ter-
ao, 2011, 2012). Although AO catalyzes the biotransformation
of several endogenous compounds, the absolute primary phys-
iological function of AO is yet to be determined. The physiolog-
ical importance of aldehyde oxidase’s role in aldehyde
oxidation is in question due to the fact that the Michaelis con-
stant (Km) for AO is higher for aliphatic aldehydes than is that
of another mammalian enzyme, aldehyde dehydrogenase
(ALDH) [EC; 1.2.1.3] (Jakoby and Ziegler, 1990; Panoutsopo-
ulos et al., 2004). Two notable endogenous substrates for AO
include retinaldehyde and pyridoxal (Beedham, 2001; Garattini
et al., 2003, 2008; Garattini and Terao, 2011, 2012; Huang
et al., 1999; Kitamura et al., 2006). Retinaldehyde is the princi-
ple component of visual pigments and for this reason it has
been suggested that aldehyde oxidase may play an important
part in the overall visual process since it catalyzes the biotrans-
formation of this aldehyde to its corresponding carboxylic acid,
and retinoic acid, which is the active form of vitamin A (Calzei
et al., 1995; Garattini et al., 2008; Garattini and Terao, 2011,
2012; Huang et al., 1999; Stanulovic and Chaykin, 1971). The
involvement of AO in all-trans retinaldehyde oxidation to all-
trans retinoic acid was ﬁrst seen in rabbit liver cytosol, where
it was observed that a fraction of the oxidizing activity did
not require an addition of NAD+ and was due to a molyb-
do-ﬂavoenzyme (Garattini et al., 2008; Tomita et al., 1993;
Tsujita et al., 1994). As well as its ability to catalyze the bio-
transformation of vitamin A metabolite (Fig. 1) AO also con-
verts vitamin B6 (pyridoxal) to 4-pyridoxic acid (Fig. 1)
(Tomita et al., 1993). Vitamin B6 is a water-soluble compound
that contains a pyridine ring. Vitamin B6 is present in nature in
several different forms such as pyridoxal (PL), pyridoxine
(PN), pyridoxamine (PM) and their active form pyridoxal 50-
phosphate (PLP) (Fitzpatrick et al., 2007). PLP is the coenzy-
matically active form of vitamin B6 and plays an important role
in maintaining the biochemical homeostasis of the body (Mei-
ster, 1990). There are more than 100 PLP-dependent enzymes in
a cell that perform essential roles in various metabolic path-
ways including amino acid metabolism (such as amino acid syn-
thesis and degradation), fatty acid metabolism (such as
synthesis of polyunsaturated fatty acids) and carbohydrate
metabolism (such as breakdown of glycogen) (Mooney et al.,
2009). The preferred degradation route from PLP to 4-pyri-
doxic acid involves the dephosphorylation of PLP by phospha-
tase (Jang et al., 2003) followed separately by the actions of
aldehyde oxidase and b-nicotinamide adenosine dinucleotide-
dependent dehydrogenase (Schwartz and Kjeldgaard, 1951;
Stanulovic et al., 1976). In mice Garattini et al. (2008) reported
that pyridoxal can be oxidized by puriﬁed mouse aldehyde oxi-
dase AOX1 and AOH1, although it is not an efﬁcient substrate
in the case of AOH2. Although a wealth of data is available onendogenous substrates of AO they are still being sought (Garat-
tini et al., 2009).
The activity of AO between animal species varies depending
on the substrate considered. Sugihara et al. found the activity
of AO in monkeys is higher than in humans when using N1-
methylnicotinamide and benzaldehyde as substrates (Sugihara
et al., 2006). Klecker et al. (2006) found the activity of AO is
highest in mouse toward zebularine substrate than in monkeys
and humans (Klecker et al., 2006). Species differences have
also been found when using cinchonidine as a substrate where
rabbits have higher AO activity than monkeys (Fukiya et al.,
2010).
Therefore, the present study investigates the role of AO in
the metabolism of pyridoxal and all-trans retinaldehyde in par-
tially puriﬁed rabbit liver fractions. The speciﬁcity of liver rab-
bit AO for these substrates was quantitatively explored by
determining kinetic constants for a variety of endogenous
compounds.
2. Materials and methods
2.1. Chemicals
All chemicals and reagents were obtained from Fisher Scien-
tiﬁc and Sigma/Aldrich Chemical Company Ltd., Poole, UK.
Mobile phase reagents and solvents were obtained from vari-
ous companies but were all for HPLC grade purity.
2.2. Preparation of aldehyde oxidase fractions
The New Zealand white male rabbit liver sample was isolated,
apportion was taken, weighed, chopped and placed immedi-
ately in 3–4 volumes of ice-cold isotonic potassium chloride
solution (1.15% KCl w/v) containing 0.1 mM EDTA and
homogenized on ice in a homogenizer ﬁtted with a Teﬂon pes-
tle for 1–2 min at 4 C. The resulting homogenate was then
heated at 55–57 C for 10 min on a steam bath and ammonium
sulfate precipitation as described by Beedham et al. (1995).
Rabbit liver fraction was stored in liquid nitrogen until used
for spectrophotometric and HPLC analyses.
2.3. Spectrophotometric measurement of enzyme activity
All spectrophotometric aldehyde oxidase assays were con-
ducted using a microplate reader spectrophotometer (BioTek).
All assays were carried out in triplicate in 100 ll reaction vol-
umes. All cytosol samples were frozen and thawed only once,
and the spectrophotometric data were collected at 5 s intervals
for 3–5 min using Gen5 software on a Windows XP PC con-
nected to the microplate reader spectrophotometer (BioTek).
Enzyme activity of partially puriﬁed fractions was monitored
using all-trans-retinal and pyridoxal. Oxidation of 0.1 mM
pyridoxal was then monitored at 388 nm and of 0.1 mM all-
trans-retinal was monitored at 380 nm as substrates in the
presence of molecular oxygen as the electron acceptor using
the molar extinction coefﬁcients for pyridoxal and all-trans-
retinal which are 4900 M1 cm1 and 43,400 M1 cm1,
respectively (Peterson and Sober, 1954; Ja¨ger et al., 1996).
All reactions were carried out in phosphate buffer saline, pH
7.4 at 37 C.
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Figure 1 Conversion of retinal (vitamin A) to its corresponding carboxylic acid (retinoic acid) and oxidation of vitamin B6 (pyridoxal)
to its corresponding carboxylic acid (4-pyridoxic acid) catalyzed by aldehyde oxidase. Based on Macrae et al., 1984; Tomita et al., 1993.
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The amount of protein in each sample was calculated using a
modiﬁcation of the method described by Smith et al. using bo-
vine serum albumin (BSA) as standard (Smith et al., 1985).
The concentration of protein in initial rabbit liver fraction
was 38.9 ± 9.6 mg/ml. The bicinchoninic acid (BCA) based as-
say is available as a kit from Sigma–Aldrich Co.
2.5. Incubations with partially puriﬁed aldehyde oxidase
fractions
Pyridoxal and all-trans-retinal (0.1 mM) were incubated with
0.1 ml partially puriﬁed rabbit liver fractions at 37 C in a total
volume of 1 ml 67 mM phosphate buffer saline, pH 7.4. Incu-
bations were performed in 1 ml closed vials which were placed
in a Dri-Block heater (DB-2D, Techne, UK) and pre-warmed
to 37 C. Aliquots (200 ll) were removed at 5, 10 and 15 min
and added to either 100 ll of 20% trichloroacetic acid to ter-
minate the reaction. Samples were centrifuged in a Microfuge
16 Centrifuge (Beckman Coulter) at 10,000 rpm for 1 min and
the supernatants were subsequently analyzed by HPLC. In all
in vitro assays no spontaneous oxidation of any substrate was
observed when control incubations were carried out without
cytosol.2.6. HPLC analysis of all-trans retinal and pyridoxal oxidation
HPLC analysis was carried out using a system supplied by
Beckman system gold, with solvent modules (127 pumps)
and a programmable diode array detector (module 168). Chro-
matographic separation was achieved using a LiChrospher
RP-18 column (C18; 250 mm · 4 mm I.D.5 lM) protected with
a guard column (lBondapak C18 Guard). All mobile phases
and HPLC methods for the above compounds are summarized
in Table 1. Oxidized metabolites were identiﬁed by comparison
of their HPLC retention times and UV spectra with those of
authentic standards.
2.7. Determination of kinetic constants for oxidation of all-trans
retinal and pyridoxal by aldehyde oxidase
UV Determination: Km (Michaelis–Menten constant) and
Vmax (maximum initial velocity) values for the oxidation of
all-trans retinal and pyridoxal with rabbit liver fractions were
determined spectrophotometrically using a method similar to
that described by Beedham et al. (1990). Kinetic constant val-
ues were determined using molecular oxygen as an electron
acceptor. At least eight different substrate concentrations were
used in the range of Km values in 67 mM phosphate buffer sal-
ine, pH 7.4. The spectrophotometric method was determined
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70 K.S. Al salhenby measurement of the gradient of the line recorded on the
curve and expressed as the change in absorbance/time. An Ea-
die Hofstee V/[S] versus [S] was then plotted. The intercept on
the ordinate axis is Vmax; the slope is Km. The line of best ﬁt
through the points on the plot was determined using linear
regression by least squares method using Microsoft Excel
(Microsoft Ofﬁce).
3. Results and discussion
Activities of the molybdenum hydroxylase fraction from rabbit
liver were measured spectrophotometrically using 0.1 mM ﬁnal
substrate concentrations of all-trans retinal and pyridoxal spe-
ciﬁc substrates of aldehyde oxidase (Tomita et al., 1993; Mac-
rae et al., 1984). The ratio of oxidation rates of all-trans retinal
and pyridoxal was calculated to reﬂect the relative aldehyde
oxidase activity in the rabbit liver investigated (Table 2). The
results demonstrate the high aldehyde oxidase activity of rab-
bit liver toward pyridoxal was much higher than all-trans ret-
inal substrate (Table 2). In order to determine that there was
deﬁnitely activity present in the rabbit liver for these endoge-
nous substrates a HPLC assay was performed with these sub-
strates. This is shown in Fig. 2, where the product (4-pyridoxic
acid and retinoic acid) was detected even after extended incu-
bation periods. In agreement with the present result Schwartz
and Kjeldgaard, 1951 found that pyridoxal, the vitamin B6
precursor, is oxidized to 4-pyridoxic acid by the human en-
zyme (Schwartz and Kjeldgaard, 1951), pyridoxal was rapidly
oxidized to 4-pyridoxic acid by the liver (28.1 ± 19.3 nmol/
min/mg protein) (Merrill et al., 1994) and by the two mouse
liver aldehyde oxidases (Garattini et al., 2009). Pyridoxal is
currently the sole example of a substrate that shows a certain
degree of selectivity for a speciﬁc aldehyde oxidase protein as
it is not recognized by puriﬁed mouse (Terao et al., 2009).
These ﬁndings are consistent with Huang and Ichikawa
(1994) and Tsujita et al. (1994) who ﬁrst observed the role of
AO in the oxidation of all-trans-retinaldehyde to retinoic acid
without NAD+ in rabbit by liver AO cytosol (Huang and Ichi-
kawa, 1994; Tsujita et al., 1994).
Km and Vmax values for the formation of 4-pyridoxic acid
and retinoic acid metabolites, also determined spectrophoto-
metrically as described in Methods, by rabbit enzyme fractions
are tabulated in Table 3 and Figs. 3 and 4. The kinetic param-
eters of pyridoxal and all-trans-retinal were found to be: Km
21 ± 6.4 and 46 ± 9.1 lM, respectively and Vmax 1.84 ± 0.2
and 1.28 ± 0.1 nmol/mg/min, respectively (Mean ± Standard
deviation (SD), N= 6) for rabbit liver aldehyde oxidase using
molecular oxygen as an electron acceptor although, rabbit liver
enzyme gave the lowest km value for 4-pyridoxic acid forma-
tion (Table 3). The lowest Km value for an AO substrate was
found with pyridoxal and Km value for pyridoxal was 2 lower
than that for all-trans-retinal as a substrate. The results of this
study indicated that pyridoxal is a better substrate of rabbit
AO than all-trans-retinal (Table 3) which has been discovered
in rabbit liver cytosol (Tomita et al., 1993) and conﬁrmed using
puriﬁed preparations of mouse liver AOX1(Huang et al., 1999;
Vila et al., 2004). In other hands, retinaldehyde has been one of
the best substrates not only of mouse AO, but also of aldehyde
dehydrogenases (Duester, 2000; Vasiliou and Nebert, 2005)
which have long been known to catalyze the oxidation of ret-
inaldehyde and to play a critical role in the morphogenetic
Table 2 All-trans retinal and pyridoxal oxidase activities in partially puriﬁed rabbit liver fraction.
Enzyme fraction All-trans retinal oxidase activity (nmol/
min/mg protein) (0.1 mM)
Pyridoxal oxidase activity (nmol/
min/mg protein) (0.1 mM)
Rabbit liver aldehyde
oxidase (N= 6)
13.3 ± 4.1 25.2 ± 12.7
The values are expressed as means ± SD.
Figure 2 HPLC-UV analysis of the in vitro biotransformation of endogenous compounds (pyridoxal and all-trans retinal) by partially
puriﬁed rabbit liver fraction. HPLC chromatograms are offset on the vertical axis to allow comparison between different incubation times.
(a) Incubation rabbit liver fraction with pyridoxal at 37 C for 0 (blue line) and 15 min (red line) (b) Incubation rabbit liver fraction with
all-trans retinal. Blue line is a zero minute incubation and red line for 15 min incubation.
In vitro oxidation of aldehyde oxidase from rabbit liver: Speciﬁcity toward endogenous substrates 71activity of retinoic acid during the development of the verte-
brate embryo (Duester, 2008). A similar ﬁnding of pyridoxal
oxidase has been made in detailed studies of the enzyme puri-
ﬁed from rabbit liver, which had higher activity (Choi et al.,
1983). This activity agrees well with the pharmacokinetics of
vitamin B6 metabolism in humans (Wozenski et al., 1980)
and other animals (Colombini and McCoy, 1970; Johanssonet al., 1974). Furthermore, this study conﬁrmed that hydropho-
bicity enhances afﬁnity of pyridoxal and all-trans-retinal (aro-
matic aldehyde) toward AO as excellent substrates (Beedham,
2001; Garattini and Terao, 2013; Panoutsopoulos et al., 2004).
However, species variation in the levels of aldehyde oxidase
has been reported (Beedham, 1987; Rashidi and Nazemiyeh,
2010). This marked variation in substrate speciﬁcity of alde-
Figure 3 Eadie-Hofstee plot for the oxidation of pyridoxal by rabbit liver aldehyde oxidase. The substrate concentrations were between
25–100 lM.
Figure 4 Eadie-Hofstee plot for the oxidation of all-trans-retinal by rabbit liver aldehyde oxidase. The substrate concentrations were
between 25–100 lM.
Table 3 Kinetic constants for molybdo-ﬂavoenzyme substrates by partially puriﬁed rabbit liver determined by spectrophotometer.
Enzyme fraction Substrates Km (lM) Vmax (nmol/min/mg) protein
Rabbit liver aldehyde oxidase (N= 6) Pyridoxal 21 ± 6.4 1.84 ± 0.2
All-trans-retinal 46 ± 9.1 1.28 ± 0.1
The values are expressed as means ± SD.
72 K.S. Al salhenhyde oxidase would make it difﬁcult to extrapolate the results
obtained from one animal to another. For instance, carbazeran
is a good substrate for guinea-pig, baboon and human liver
aldehyde oxidase, whereas it does not serve as a substrate for
rabbit enzyme (Beedham, 1987). Conversely, methotrexate is
a more efﬁcient substrate for rabbit liver aldehyde oxidase
than that of other species (Kitamura et al., 1999). Further-
more, the site of substrate oxidation catalyzed by aldehyde oxi-
dase may be species-dependent. N1-methylnicotinamide is
oxidized to two metabolites, a 2-pyridone (N1-methyl-2-pyri-
done-5-carboxamide) and a 4-pyridone (N1-methyl-4-pyri-
done-3-carboxamide) by liver aldehyde oxidase from various
species; however, the ratio of the 4-pyridone to the 2-pyridone
metabolite differs from one species to another (Stanulovic and
Chaykin, 1971).
It is concluded that difference in activities of endogenous
substrates metabolizing aldehyde oxidase may be controlled
by a number o factors such as gene sequence, protein structure
and hormonal regulation of AO activity (Beedham, 2001 and
Beedham, 2010). Overall, the data presented serve as a guide
for predicting the susceptibility of endogenous to oxidationby rabbit liver aldehyde oxidase, because the species variation
and substrate speciﬁcity of this enzyme indicates that this en-
zyme has a relatively large active/binding site with a marked
ﬂexibility from one animal to another (Beedham, 1987; Garat-
tini and Terao, 2013; Rashidi and Nazemiyeh, 2010).
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